ENLV: Rega marang dodolan Enlivex Therapeutics Ltd

Logo korporat perusahaan Enlivex Therapeutics, Ltd. (ENLV)

A bet on academic alliances over mergers is driving growth, and on the GURU.Markets platform, the P/S ratio dynamics visualize this trend, where the value of confirms the current level. The business foundation of Enlivex Therapeutics (ENLV) relies on the commercialization of Allocetra for sepsis therapy, while supply reliability is ensured by climate-controlled express aviation, which is critical for intensive care biologics.

ENLV Rasio rega marang pendapatan Enlivex Therapeutics, Ltd. (04.07.2022 - 16.11.2026)

Rincian analitis perusahaan Enlivex Therapeutics, Ltd. (ENLV)

Ringkesan analitik perusahaan:Enlivex Therapeutics, Ltd. ENLV
Sampel barang Enlivex Therapeutics Ltd

The investment attractiveness of Enlivex Therapeutics (ENLV) is based on unique patents in the field of cell therapy. The P/S ratio compares current market capitalization to annual revenue, determining the cost of one dollar of sales. By analyzing the P/S market multiple, an investor can discern the degree of asset overvaluation relative to actual income. This allows for an assessment of business resilience amid strict regulatory control and the complexities of biomanufacturing.

Perusahaan pesaing

argenx - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (biontech.de)|Abivax Corp (ABVX) - Rega marang dodolan|ADMA Corp - Multiplikator P/S|Rasio rega marang dodolan PTGX|Immunovant Inc (IMVT) - Rasio rega marang pendapatan|KNSA - Koefisien rega marang pendapatan|GRFS (Grifols Biemat) - Multiplikator P/S|Multiplikator P/S Adaptive Biotechnologies Inc.|Rasio rega marang pendapatan Celldex Therapeutics (CLDX)|Koefisien rega marang pendapatan auriniapharma.com|Rasio rega marang pendapatan BioCryst Pharmaceuticals BCRX|Rasio kapitalisasi pasar marang pendapatan VERA|Dianthus Pharma - Multiplikator P/S|PHVS - Multiplikator P/S|ABCL: Multiplikator P/S|TRML (Tourmaline Bio, Inc.) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Intrexon|PHAR - Multiplikator rega marang pendapatan|Multiplikator P/S NKTR|Rasio rega marang pendapatan UPB (Upstream Bio Corp)|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|Koefisien rega marang pendapatan immunome.com (IMNM)|Gossamer Bio Inc - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Multiplikator P/S|Kapitalisasi marang pendapatan Pieris Pharmaceuticals Inc|Kapitalisasi marang pendapatan SVRA|Kapitalisasi marang pendapatan Rigel Pharmaceuticals (RIGL)|Multiplikator P/S ANAB|ATXS - Rega marang dodolan|Rasio rega marang pendapatan enGene Corp ENGN|Koefisien rega marang pendapatan RAPT Therapeutics, Inc. (RAPT)|Aerovate - Multiplikator P/S|ACRS - Multiplikator P/S|KYTX (Kyverna Therapeutics) - Kapitalisasi marang pendapatan|Rega marang dodolan Tiziana Life Sciences Ltd. (TLSA)|Kapitalisasi marang pendapatan CABA|Ventyx Biosciences (VTYX) - Koefisien rega marang pendapatan|Multiplikator P/S THTX|AVTX (Avalo Therapeutics, Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ELDN (eledon.com)|AGEN - Kapitalisasi marang pendapatan|CLYM - Rasio rega marang pendapatan|Rasio rega marang dodolan ZURA|ATYR: Multiplikator P/S|Adagene Corp (ADAG) - Multiplikator P/S|Kapitalisasi marang pendapatan IMA|Shattuck Labs, Inc. - Rasio rega marang dodolan|Rasio rega marang pendapatan Equillium Inc (EQ)|Multiplikator P/S Connect Biopharma Holdings (CNTB)|Rasio rega marang pendapatan Immunic, Inc. IMUX|Multiplikator P/S Atara Biotherapeutics ATRA|IFRX - Rasio rega marang pendapatan|XFOR: Rasio rega marang pendapatan|ACET: Multiplikator P/S|CELU - Koefisien rega marang pendapatan|Rasio rega marang pendapatan inmunebio.com|Rasio kapitalisasi marang pendapatan BRNS (barinthusbio.com)|Multiplikator P/S KZR|Multiplikator P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator P/S AKTX (Akari Therapeutics, Plc)|q32bio.com - Rasio rega marang pendapatan|GOVX: Kapitalisasi marang pendapatan|edesabiotech.com (EDSA) - Kapitalisasi marang pendapatan|IBIO: Multiplikator P/S|CARM - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan XTLB|Kapitalisasi marang pendapatan boltbio.com (BOLT)|Rasio rega marang pendapatan HCW Biologics Inc (HCWB)|Multiplikator P/S Aptevo Therapeutics, Inc. (APVO)|Rasio rega marang pendapatan aimimmuno.com AIM|Rasio kapitalisasi pasar marang pendapatan ADTX|GRI Bio Corporation - Multiplikator P/S|XORTX Corp (XRTX) - Kapitalisasi marang pendapatan|HIND (Vyome Holdings Inc.) - Kapitalisasi marang pendapatan|revbiosciences.com (REVB) - Multiplikator P/S|INDP (Indaptus Corp) - Multiplikator P/S|Kapitalisasi marang pendapatan Scinai Immunotherapeutics Ltd (SCNI)|Rasio rega marang pendapatan CalciMedica Inc (CALI)|AFMD (Affimed NV) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ALLK (Allakos Inc.)|Multiplikator P/S HOOKIPA HOOK|IGMS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ITOS (iTeos)|OCEA: Multiplikator P/S|TCBP (TC BioPharm Ltd) - Rasio rega marang pendapatan|THRD (Third Harmonic Bio Inc) - Multiplikator P/S